PRQR — ProQR Therapeutics NV Share News
0.000.00%
Last trade - 00:00- $182.05m
- $68.00m
- €16.35m
U.S. STOCKS ON THE MOVE-Moderna, Beauty Health, Boston Beer
ProQR Therapeutics gains on license agreement with Eli Lilly
Brief: Proqr Announces Axiomer Rna Editing Licensing And Research Collaboration With Lilly
Brief: Proqr Announces Axiomer RNA Editing Licensing And Research Collaboration With Lilly
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:10 PM
ProQR Therapeutics NV reports results for the quarter ended in June - Earnings Summary
ProQR Therapeutics NV expected to post a loss of 22 cents a share - Earnings Preview
ProQR Therapeutics NV reports results for the quarter ended in March - Earnings Summary
Brief: Proqr Announces First Quarter 2021 Operating And Financial Results
Brief: Proqr Therapeutics NV Reports Q1 Loss Per Share EUR 0.25
ProQR Therapeutics NV expected to post a loss of 25 cents a share - Earnings Preview
Brief: Proqr Announces Publication In Nature Medicine For Sepofarsen In Leber Congenital Amaurosis 10
Brief: ProQR Announces Virtual Presentation At American Association For Pediatric Ophthalmology And Strabismus 2021
U.S. STOCKS ON THE MOVE-Chewy, VirTra, Blackberry, Humanigen
ProQR Therapeutics down after $90 mln equity raise
Brief: ProQR Therapeutics Says Prices $90 Mln Underwritten Public Offering Of Ordinary Shares
Brief: ProQR Announces Proposed Underwritten Public Offering Of Ordinary Shares
Brief: ProQR Announces Proposed Underwritten Public Offering Of Ordinary Shares
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:41 AM